Search result for 'swiss parenterals'

Eris Lifesciences to acquire remaining 30% stake in Swiss Parenterals via share swap. Naishadh Shah to become Managing Director.

Eris Lifesciences reported a 20% decline in Q2 profit to Rs 97 crore, but revenue increased to Rs 741 crore. The company is on track to achieve revenue guidance of Rs 2,600 crore in domestic...

Eris Lifesciences has acquired a 51% stake in Swiss Parenterals, a leading sterile injectable manufacturer, for Rs 637.5 crore. The acquisition strengthens Eris's India footprint and complements...